Pharmacists News

• Pfizer Says COVID-19 Vaccine Response Robust in Young Children Much anticipated findings from Pfizer/BioNTech suggest three doses of COVID-19 vaccine protect kids ages 6 months to 5 years old.
  WebMD Health News, May 23, 2022
• SGLT-2 inhibitors as First-Line Therapy in Type 2 Diabetes? Real-world study finds heart failure hospitalization reduction compared to metformin but not MI, stroke, or overall mortality, and greater genital infection risk.
  Medscape Medical News, May 23, 2022
• Cancer Coalition Aims to Boost Access to Meds in Poorer Countries Pharmaceutical companies including Novartis and Roche have teamed up with global cancer organizations in an alliance aimed at getting more oncology medications to poorer countries.
  Reuters Health Information, May 20, 2022
• Postpolypectomy Bleeding: Does Prophylactic Clipping Reduce Risk? The removal of polyps has a high risk of hemorrhage, which may be increased with the use of oral anticoagulants.
  Medscape Medical News, May 23, 2022
• Combining Allergic Rhinitis Treatments May Improve Symptoms If one treatment for allergic rhinitis doesn't improve symptoms, combining it with other treatments may work, researchers in Thailand report.
  Medscape Medical News, May 23, 2022
• Zolpidem Restrictions: How Are General Practitioners Coping? Most practitioners who participated in a French study described the restrictions as helpful for promoting discontinuation and, at the same time, problematic.
  Medscape Medical News, May 23, 2022
• Adolescents With Food Allergies Share Common Concerns Adolescents with food allergies have allergy-related beliefs and concerns that involve five themes that may influence how they manage their condition, researchers report.
  Medscape Medical News, May 23, 2022
• How to Manage Drug Interactions With Paxlovid for COVID Some drugs can be held or reduced for the 5-day course. IDSA has published an online guide. Availability in pharmacies has greatly increased in recent weeks.
  Medscape Medical News, May 20, 2022
• Allergen-Specific Immunotherapy During Pregnancy Appears Safe for Babies Maintaining allergen-specific immunotherapy (AIT) during pregnancy shows no evidence of raising the risk of congenital malformations or other adverse pregnancy outcomes, according to a nationwide study from Sweden.
  Reuters Health Information, May 19, 2022
• FDA Approves First Drug for Eosinophilic Esophagitis Dupilumab (Dupixent) is approved to treat eosinophilic esophagitis in adults and children aged 12 years and older weighing at least 40 kg.
  FDA Approvals, May 20, 2022
• Alert Baricitinib Backed for Approval for Alopecia Areata in the EU In February 2022, the FDA granted priority review for baricitinib in adults with severe alopecia areata.
  International Approvals, May 20, 2022
• Vitamins, OTC Drugs May Interact With HIV Antiretroviral Therapy OTC medications, food supplements, and other drugs may interact with antiretroviral therapy and harm people living with HIV, researchers in Denmark report.
  Medscape Medical News, May 20, 2022
• AACE 2022 Debate Continues on Combination Therapy for Hypothyroidism Clinicians shouldn't dismiss patients who complain about residual symptoms despite TSH normalization with levothyroxine, say thyroid experts who have rekindled a long-running debate at the AACE meeting.
  Medscape Medical News, May 20, 2022
• Prostate Cancer Survival: Enzalutamide Edges Out Abiraterone Men with metastatic disease who received enzalutamide demonstrated a small but significant survival benefit. The study was published as a preprint and has not yet been peer reviewed.
  Medscape Medical News, May 20, 2022
• CDC Signs Off on COVID Boosters in Children Ages 5-11 An advisory panel also called for stepped-up efforts to make sure children get their initial vaccines.
  Medscape Medical News, May 19, 2022
• Rabies: CDC Updates PrEP Vaccination Recommendations In trying to simplify recommendations and make rabies immunization less expensive, the CDC designated five risk levels with different advice based on the level of risk.
  Medscape Medical News, May 19, 2022
• Experts Urge Stopping Melanoma Trial Because of Failure and Harm New results from a phase 3 trial may shut the door on the addition of PD–1 or PD–ligand 1 inhibitors to the combination of BRAF and MEK inhibitors for the treatment of BRAF V600–mutated melanoma.
  Medscape Medical News, May 19, 2022
• NeoChemo Preserves Rectum in Half of Patients With Rectal Cancer Among patients with stage II or stage III rectal adenocarcinoma, organ preservation is achievable in up to half of patients who undergo total neoadjuvant chemotherapy.
  Medscape Medical News, May 19, 2022
• ACMS 2022 Post-Mohs Bleeding Risk in Patients on Ibrutinib for CLL Studied Two studies evaluated the risk, with results indicating that holding the treatment before and after surgery helps reduce the risk for bleeding.
  Medscape Medical News, May 18, 2022
• EuroPCR 2022 One-Month DAPT Enough for Complex PCI if Bleeding Risk High Latest data from the MASTER DAPT trial show similar results in the subgroup of patients who underwent complex PCI as in the main trial.
  Medscape Medical News, May 18, 2022